TKT and neoplasm: One of the outstanding candidates developed so far is Pexa-Vec (JX-594) a thymidine-kinase (TK)-deleted Wyeth strain of VACV expressing the granulocyte-macrophage colony-stimulating factor (GM-CSF) cytokine to activate immune cells at the tumor site.8